HIGHLIGHTS
- who: Sarah Zierold from the Germany Department of Medicine III, University have published the Article: Checkpoint-inhibitor induced Polyserositis with Edema, in the Journal: (JOURNAL)
- what: The authors show that peripheral edema can occur.
SUMMARY
Immune checkpoint inhibitors (ICI) are increasingly important due to their effectiveness in various tumor entities. Currently, mainly case reports of pericardial effusion under nivolumab in patients with advanced non-small cell lung cancer (NSCLC) are available. While one report indicates it is a negative prognostic factor in patients with NSCLC, another report documents that the detection . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.